Pinnacle Associates Ltd. Has $1.78 Million Holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH)

Pinnacle Associates Ltd. grew its holdings in Prestige Consumer Healthcare Inc. (NYSE:PBH - Free Report) by 60.3% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 24,630 shares of the company's stock after purchasing an additional 9,269 shares during the period. Pinnacle Associates Ltd.'s holdings in Prestige Consumer Healthcare were worth $1,776,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. Ariel Investments LLC raised its holdings in shares of Prestige Consumer Healthcare by 10.7% in the second quarter. Ariel Investments LLC now owns 2,835,203 shares of the company's stock valued at $195,204,000 after purchasing an additional 274,212 shares during the last quarter. Victory Capital Management Inc. increased its holdings in Prestige Consumer Healthcare by 9.0% during the second quarter. Victory Capital Management Inc. now owns 2,074,460 shares of the company's stock worth $142,827,000 after buying an additional 171,357 shares during the last quarter. Allspring Global Investments Holdings LLC increased its holdings in Prestige Consumer Healthcare by 19.3% during the third quarter. Allspring Global Investments Holdings LLC now owns 1,575,170 shares of the company's stock worth $113,570,000 after buying an additional 255,045 shares during the last quarter. Boston Trust Walden Corp acquired a new position in Prestige Consumer Healthcare during the third quarter worth $41,785,000. Finally, The Manufacturers Life Insurance Company increased its holdings in Prestige Consumer Healthcare by 0.8% during the second quarter. The Manufacturers Life Insurance Company now owns 543,401 shares of the company's stock worth $37,413,000 after buying an additional 4,305 shares during the last quarter. 99.95% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on PBH shares. Jefferies Financial Group restated a "hold" rating and set a $76.00 target price (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th. DA Davidson boosted their target price on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the stock a "buy" rating in a report on Wednesday, August 28th. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $94.20.

Prestige Consumer Healthcare Stock Performance

PBH stock traded up $0.30 during midday trading on Friday, reaching $74.05. 260,044 shares of the company were exchanged, compared to its average volume of 229,907. The company has a debt-to-equity ratio of 0.65, a current ratio of 3.23 and a quick ratio of 1.90. The business has a 50-day moving average price of $72.17 and a two-hundred day moving average price of $69.56. Prestige Consumer Healthcare Inc. has a one year low of $56.61 and a one year high of $75.80. The firm has a market capitalization of $3.67 billion, a price-to-earnings ratio of 18.11, a price-to-earnings-growth ratio of 2.08 and a beta of 0.47.

Prestige Consumer Healthcare (NYSE:PBH - Get Free Report) last announced its earnings results on Thursday, August 8th. The company reported $0.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.86 by $0.04. The company had revenue of $267.10 million during the quarter, compared to analysts' expectations of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. Prestige Consumer Healthcare's quarterly revenue was down 4.4% on a year-over-year basis. During the same quarter in the previous year, the business posted $1.06 earnings per share. Equities research analysts forecast that Prestige Consumer Healthcare Inc. will post 4.43 EPS for the current year.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.